Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report specifically details a transaction in the company's own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | April 1, 2025 |
| Shares Purchased | 828,379 |
| Highest Price Paid | 396.80 pence |
| Lowest Price Paid | 388.70 pence |
| Volume Weighted Average Price | 392.34 pence |
| Registered Share Capital | 9,037,328,412 ordinary shares |
| Treasury Shares Held | 4,080,205 |
| Voting Shares Outstanding | 9,033,248,207 |
Material Changes
Following the settlement of the repurchase transaction, the company's share capital structure was updated. The number of ordinary shares with voting rights is now 9,033,248,207. This figure is material for shareholders determining notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a regulatory disclosure of a specific capital transaction. The announcement explicitly states it does not constitute an offer or solicitation of an offer for securities.
Investor Verification Checklist
- Verify the total number of voting shares (9,033,248,207) for compliance with disclosure thresholds.
- Confirm the settlement of the 828,379 shares purchased on April 1, 2025.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular pricing data.
- Note that this filing does not contain operational or financial performance data for the period.